Phio Financial Statements From 2010 to 2025

Phio Pharmaceuticals Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 5.5 M 5.7 M 10 M Slightly volatile Short and Long Term Debt Total 29.9 K 31.5 K 377.3 K Slightly volatile Other Current Liabilities 1.3 M 762 K 1.2 M Pretty Stable Total Current Liabilities 1.6 M 1 M 1.9 M Very volatile Property Plant And Equipment Net 1.9 K 2 K 252.9 K Pretty Stable Current Deferred Revenue 1.5 M 1.4 M 931.7 K Slightly volatile Accounts Payable 240.3 K 253 K 533 K Very volatile Cash 10.4 M 5.4 M 9 M Slightly volatile Non Current Assets Total 1.9 K 2 K 274.2 K Pretty Stable Cash And Short Term Investments 5.1 M 5.4 M 9.2 M Slightly volatile Net Receivables 477.6 K 537.3 K 585.8 K Slightly volatile Common Stock Total Equity 855 900 3.6 K Slightly volatile Common Stock Shares Outstanding 8.3 M 7.9 M 1 M Slightly volatile Liabilities And Stockholders Equity 5.5 M 5.7 M 10 M Slightly volatile Other Current Assets 490.2 K 354 K 435.5 K Slightly volatile Other Stockholder Equity 95.3 M 151.1 M 82.1 M Slightly volatile Total Liabilities 964.2 K 1 M 3.4 M Slightly volatile Property Plant And Equipment Gross 403.1 K 308 K 368.1 K Slightly volatile Total Current Assets 5.4 M 5.7 M 9.7 M Slightly volatile Short Term Debt 29.9 K 31.5 K 248.8 K Pretty Stable Common Stock 855 900 3.6 K Slightly volatile Other Liabilities 21.6 K 24.3 K 26.5 K Slightly volatile Non Currrent Assets Other 3.3 K 3.5 K 23.1 K Very volatile Preferred Stock Total Equity 3.4 M 3.2 M 4.4 M Slightly volatile Property Plant Equipment 268.2 K 478.4 K 275.8 K Slightly volatile Net Tangible Assets 26.5 M 25.2 M 13.6 M Slightly volatile Warrants 5.2 M 4.6 M 5.8 M Slightly volatile Capital Surpluse 86 M 134.1 M 82.4 M Slightly volatile Long Term Investments 120 K 135 K 147.2 K Slightly volatile Net Invested Capital 4.5 M 4.7 M 6.1 M Slightly volatile Net Working Capital 4.5 M 4.7 M 5.8 M Slightly volatile Non Current Liabilities Other 282.4 K 265.5 K 364.9 K Slightly volatile Long Term Debt 184.8 K 207.9 K 226.7 K Slightly volatile Long Term Debt Total 184.8 K 207.9 K 226.7 K Slightly volatile
Phio Pharmaceuticals Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 33.2 K 35 K 106.9 K Pretty Stable Other Operating Expenses 9 M 9.7 M 11.1 M Slightly volatile Research Development 5.5 M 3.6 M 6.8 M Slightly volatile Total Operating Expenses 8.4 M 7.4 M 10.5 M Slightly volatile Selling General Administrative 4.2 M 3.7 M 3.7 M Slightly volatile Cost Of Revenue 33.2 K 35 K 6 M Slightly volatile Preferred Stock And Other Adjustments 3 M 1.9 M 3.8 M Slightly volatile Interest Income 855 900 7.5 K Slightly volatile Non Recurring 3.8 M 4.2 M 4.6 M Slightly volatile Reconciled Depreciation 33.2 K 35 K 81.5 K Pretty Stable Selling And Marketing Expenses 147.2 K 165.6 K 180.6 K Slightly volatile
Phio Pharmaceuticals Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Stock Based Compensation 139.7 K 147 K 863.6 K Slightly volatile Begin Period Cash Flow 10.6 M 8.5 M 9.5 M Slightly volatile Depreciation 33.2 K 35 K 100 K Slightly volatile Capital Expenditures 950 1000 52.8 K Pretty Stable End Period Cash Flow 10.5 M 5.4 M 9 M Slightly volatile Dividends Paid 4.9 M 4.7 M 1.9 M Slightly volatile Issuance Of Capital Stock 6.9 M 4 M 13.6 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 275 186 267 Very volatile Dividend Yield 0.0092 0.0096 0.0426 Slightly volatile Stock Based Compensation To Revenue 21.55 16.43 18.5854 Very volatile Capex To Depreciation 0.0271 0.0286 0.5757 Pretty Stable Payables Turnover 0.13 0.1383 16.4444 Slightly volatile Sales General And Administrative To Revenue 212 202 141 Slightly volatile Research And Ddevelopement To Revenue 94.68 184 136 Slightly volatile Capex To Revenue 2.06 3.09 2.4842 Slightly volatile Cash Per Share 0.65 0.6835 118.6 K Slightly volatile Days Payables Outstanding 4.6 K 2.6 K 5 K Pretty Stable Income Quality 0.67 0.9947 0.8421 Slightly volatile Current Ratio 4.3 5.6512 5.0209 Slightly volatile Capex Per Share 1.0E-4 1.0E-4 1.5 K Slightly volatile Revenue Per Share 5.38 5.67 3.5 K Slightly volatile Interest Debt Per Share 0.0279 0.0293 8.8 K Slightly volatile Debt To Assets 0.0041 0.0043 0.0732 Slightly volatile Days Of Payables Outstanding 4.6 K 2.6 K 5 K Pretty Stable Ebt Per Ebit 0.78 0.9679 0.9569 Pretty Stable Quick Ratio 4.3 5.6512 5.0209 Slightly volatile Net Income Per E B T 0.77 0.89 0.9176 Pretty Stable Cash Ratio 3.86 5.3025 4.4891 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 1.11 1.0001 1.0128 Slightly volatile Fixed Asset Turnover 0.0318 0.0335 0.3476 Slightly volatile Debt Ratio 0.0041 0.0043 0.0732 Slightly volatile Price Sales Ratio 275 186 267 Very volatile Asset Turnover 0.0029 0.003 0.0077 Slightly volatile
Phio Pharmaceuticals Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 5.5 M 5.8 M 10.6 M Slightly volatile

Phio Fundamental Market Drivers

Phio Upcoming Events

About Phio Pharmaceuticals Financial Statements

Pair Trading with Phio Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Phio Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phio Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.When determining whether Phio Pharmaceuticals Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Phio Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Phio Pharmaceuticals Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Phio Pharmaceuticals Corp Stock:

How To Invest In Phio Details

Is Phio Stock a good investment? Details

What is Phio Pharmaceuticals' Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details